{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-204310","form_type":"8-K","ticker":"JAGX","cik":"0001585608","company_name":"Jaguar Health, Inc.","filed_at":"2026-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.526184+00:00","generated_at":"2026-05-14T23:54:40.422401+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Jaguar Health cures Nasdaq publicly held shares deficiency via warrant exercises after reverse split","bullets":["Received Nasdaq notice on May 1, 2026 for non-compliance with minimum 500,000 publicly held shares after 1-for-35 reverse split on April 30.","Post-split publicly held shares were ~401,226, below the 500,000 requirement.","On May 4, 2026, warrant exercises increased publicly held shares to 513,939.","Company now has 513,974 total shares outstanding; awaiting Nasdaq formal confirmation of compliance.","Reverse split had also triggered continued non-compliance with bid price rule until cure."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-204310","json":"https://secwatch.observer/filing/0001193125-26-204310.json","markdown":"https://secwatch.observer/filing/0001193125-26-204310.md","text":"https://secwatch.observer/filing/0001193125-26-204310.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526204310/0001193125-26-204310-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526204310/d941132d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T23:54:40.422401+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}